| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $707.95 | $1,230.27 | $2,089.30 | |
Lucent Health
| Facility | $4,677.35 | $4,677.35 | $4,677.35 | |
United
| Professional | $794.33 | $1,348.96 | $3,090.30 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $707.95 | $1,230.27 | $2,089.30 | |
Lucent Health
| Facility | $4,677.35 | $4,677.35 | $4,677.35 | |
United
| Professional | $794.33 | $1,348.96 | $3,090.30 |